Views & Analysis | Perspectives on pharma industry issues

Digital

Sponsored

AI-enabled pharmacovigilance, with Updesh Dosanjh

Updesh Dosanjh, IQVIA commercialisation lead for safety technology, discusses how and why the role of AI in pharmacovigilance is changing.

Digital

Two female silhouettes in a city office overlook the urban landscape below

How female leadership can benefit industry

Day One Strategy’s founding partners Abigail Stuart and Hannah Mann share the benefits female leadership can bring to industry.

Patients

Maintenance: The underexamined half of the GLP-1 story

GLP-1 treatments have historically had an exit problem, as appetite suppression stops when the medication stops.

Oncology

pharmaphorum podcast Episode 276, Irina Babina, Concr

Getting predictive technologies to patients, with Concr

Dr Irina Babina, CEO of oncology R&D platform Concr, discusses how current regulatory frameworks were built for static diagnostics.

R&D

Concept of AI overview of patient in clinical trial

How AI simulation could help de-risk obesity and cardiometab...

AI life sciences models allow researchers to explore different patient populations, protocols, and development strategies before a study starts.

Articles

A four-step methodology in structuring payer landscapes in v...

Dr Rainer Opgen-Rhein, Giorgia Leoni and Hassan Bruneo discuss a four-step methodology in structuring payer landscapes, a useful tool for pharmaceutical companies. Current financial restrictions in most of the biggest economies have effects also in the national healthcare systems, creating new...

Articles

When your life and your business – may depend on mobile cove...

Ted Mercer looks at future of mobile health and how it could be affected by mobile signal coverage. We all from time to time get frustrated at mobile telephony coverage. Despite maps and regulators that show that only a very...

Articles

Are you extracting real value from your senior executives?

Hiring and keeping senior executives at your organisation is important to get right. Dr Wolfgang Walter, Dr Niren Thanky & Caroline Vanovermeire discuss why. Recruiting or promoting a promising executive is a challenging opportunity for both the individual and the company. It represents...

Sales & Marketing

Sponsored

Accelerating growth through strategic investment in healthca...

CEVA FORPATIENTS at Rockingham, UK will offer the healthcare supply chain a new, sustainably designed multi-user site.

Sales & Marketing

The patient communication crisis pharma can no longer ignore

Industry's significant investments in patient engagement are only effective if patients trust the communication enough to answer in the first place.

Digital

Sponsored

AI-enabled pharmacovigilance, with Updesh Dosanjh

Updesh Dosanjh, IQVIA commercialisation lead for safety technology, discusses how and why the role of AI in pharmacovigilance is changing.

Digital

How female leadership can benefit industry

Day One Strategy’s founding partners Abigail Stuart and Hannah Mann share the benefits female leadership can bring to industry.

Market Access

$100 notes in pill bottle on aquamarine background with spilled pills

How new PBM transparency rules will alter drug pricing

The complex drug pricing ecosystem means all stakeholders are scrambling to understand how the new regulations and PBMs’ adjustments will impact them.

Market Access